Medlab Clinical $6.600
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:00am | ||||
MEDLAB CLINICAL LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
Annual Report to shareholders
MDC released this announcement to the ASX on 30 August 2022, 12:17. The announcement is not marked as price sensitive, and is 72 page(s) in length and 10.4MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Annual Report to shareholders | 30 August 2022, 12:17 |
| Preliminary Final Report | 30 August 2022, 12:09 |
| MDC Notice of Annual General Meeting/Proxy Form | 29 August 2022, 10:42 |
| Biotech Investors' Conference Presentation | 17 August 2022, 15:25 |
If you were already registered, log in here.
If you were already registered, log in here.